Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed Nov 7, 2018 · 10-Q · 38 days after period end · 0001171843-18-007677
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Net Income | -$4.51M | -$12.31M | -$7.11M | -$5.38M |
| EPS Diluted | -$0.25 | -$1.08 | -$0.43 | -$0.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Sep 30, 2018 · filed Nov 7, 2018 · 38 d after period end
